Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
PhRMA Releases Report on Financial Flow in Pharmaceutical Industry
In late November, the Pharmaceutical Research and Manufacturers Association (PhRMA) released a new report examining how money…
Drug Pricing Report Released by NASEM
The most recent example of drug marketing being caught in the crossfire of the drug pricing debate can be found in a report by the…
ICER Expanding Probe
A nonprofit group, the Institute for Clinical and Economic Review (ICER), recently received a three-year $13.9 million grant from…
Changes to 340B Program Reduces Hospital Reimbursement for Pharmaceutical…
Recently, the Centers for Medicare & Medicaid Services (CMS) issued the Calendar Year (CY) 2018 Hospital Outpatient…
California Bans Prescription Discounts with Generic Equivalents
The California Assembly and Senate recently passed AB265, focused on amending price discounts permitted on prescription drugs. The…
California Enacts Legislation on Reporting of Prescription Drug Costs
California’s Senate and Assembly have both passed legislation on publishing prescription drug prices (SB-17) and presented the…
Louisiana Price Transparency Measures Go into Effect…With An Interesting…
According to LexisNexis State Net, during 2017, about half of the states and Congress collectively introduced almost 90 measures…
Chicago Proposes Drug Pricing Transparency Ordinance
Chicago Alderman Edward M. Burke recently held a hearing on the proposed city ordinance, “Chicago Drug Pricing Transparency…
After a Quiet Summer, Congress Starts Probe into MS Drugs
Congress has recently taken a few months off from constantly barraging the pharmaceutical industry with daily probes and negative…
FDA Considering Removing Regulatory Obstacles to Generic Competition
Mid-July 2017, the United States Food and Drug Administration held a public meeting to discuss options and steps to encourage…